Difference between revisions of "Team:IIT-Madras/Design"

Line 80: Line 80:
 
<center>
 
<center>
 
<div class="box" style="display: block;">
 
<div class="box" style="display: block;">
<h2 style="font-size: 9mm;">The rationale used in designing parts is as follows</h2>
+
<h2 style="font-size: 9mm;">The rationale used in designing parts:
 +
(phase dependent promoter and another promoter library)
 +
</h2>
  
 
<span style="padding-right: 73%;"><strong>Introduction:</strong></span>
 
<span style="padding-right: 73%;"><strong>Introduction:</strong></span>
Line 88: Line 90:
  
  
Acinetobacter baylyi ADP1 is an interesting organism for its natural competency and its ability to degrade aromatic compounds and lignocellulosic mass.  
+
In synthetic biology and metabolic engineering studies, the level of protein expression is very important. The expression of the protein may be phase depended, inducible or constitutive. There are various factors influencing proteins expression levels.:(Glick et al 1987)
Factors influencing Expression of protein:(Glick et al 1987)<sup><a href="#1">[1]</a></sup>
+
<sup><a href="#1">:[1]</a></sup>
 
<ul style="font-size: 5.5mm; text-align: justify; padding-left: 10mm; " ALIGN=LEFT>
 
<ul style="font-size: 5.5mm; text-align: justify; padding-left: 10mm; " ALIGN=LEFT>
  
<li>The strength of the promoter</li>
+
<li>The strength of the promoter[2]</li>
<li>The efficiency of RBS</li>
+
<li>The efficiency of RBS[3]</li>
<li>Substate cofactor availability</li>
+
<li>Substate cofactor availability[4]</li>
<li>The half life of mRNA</li>
+
<li>The half life of mRNA[5]</li>
 
<li>The metabolic state of the cell</li>
 
<li>The metabolic state of the cell</li>
 
<li>Stability of the foreign protein in the cell</li>
 
<li>Stability of the foreign protein in the cell</li>
<li>The abundance of the specific tRNA/Codon Usage table</li>
+
<li>The abundance of the specific tRNA/Codon Usage table[6]</li>
<li>The copy number of the gene encoding the protein of interest</li>
+
<li>The copy number of the gene encoding the protein of interest[7]</li>
 
<li>Protein interaction with other proteins in a chassis</li>
 
<li>Protein interaction with other proteins in a chassis</li>
 
<li>Presence of inducer or signalling molecule for Inducible promoter</li>
 
<li>Presence of inducer or signalling molecule for Inducible promoter</li>
Line 105: Line 107:
  
 
</ul>
 
</ul>
 +
  
 
</p>
 
</p>
Line 111: Line 114:
 
<p style="font-size:5.5mm; font-family: 'title', sans-serif;" class="p12 p16" ALIGN=LEFT>
 
<p style="font-size:5.5mm; font-family: 'title', sans-serif;" class="p12 p16" ALIGN=LEFT>
  
In our project, we focused on three factors, ie, Promoters, RBS and codon usage table.<br>
+
In our project, we focused on three factors, ie, Promoters, RBS and codon usage table.<br><br>
 +
 
 +
<b>Promoter</b>: it is the region upstream of the gene where RNA polymerase binds and transcription initiates. The binding of RNA polymerase to the promoter is often the rate-limiting step as in a bacterial system where translation and transcription are coupled, unlike eukaryotic system where the mRNA undergoes post-transcriptional modification. Hence promoter sequence is the major translational regulator in gene expression.<br><br>
 +
 
 +
<b>RBS</b>: It is the region just upstream of the coding region that binds to the Ribosomal unit and initiates translation. The mRNA conformation at RBS is extremely detrimental in bringing both subunits of ribosome together and initiate translation.<br><br>
 +
 
 +
<b>Codon usage</b>: Each species have a different abundance of tRNA. Hence, each species have a different preference for each codon for each amino acids. The abundance of tRNA levels can also make difference in translational rates. By process of Codon optimization, expression of genes can be increased by multiple folds.<br><br><br>
 +
 
 +
<span style="padding-right: 73%;"><strong>Promoters (using random and rational approaches):</strong></span>
  
 
Promoters usually have a construct as shown below.
 
Promoters usually have a construct as shown below.
Line 122: Line 133:
 
In region 1, it has typically about 17 Nucleotides, then the -35 conserved region which is recognized by RNA polymerase while transcription initiation. Then follows Region 2 which is about 17 nucleotides long. -10 follows which is typically TATA box. Another motif that is conserved for promoters. Then follows 6 nucleotides long Region which we named region 3 and then there is a transcription initiation site. This usually starts with A. From this site Transcription starts.<br><br>
 
In region 1, it has typically about 17 Nucleotides, then the -35 conserved region which is recognized by RNA polymerase while transcription initiation. Then follows Region 2 which is about 17 nucleotides long. -10 follows which is typically TATA box. Another motif that is conserved for promoters. Then follows 6 nucleotides long Region which we named region 3 and then there is a transcription initiation site. This usually starts with A. From this site Transcription starts.<br><br>
  
The regions flanking -35 and -10 regions ie Region 1,2 and 3 affect the strength of the promoter [6].<br><br>
+
The regions flanking -35 and -10 regions ie Region 1,2 and 3 affect the strength of the promoter [8].<br><br>
  
For our project, we used T5 promoter[BBa_K592008]. Being a viral promoter, it is constitutive and is known to express in a wide range of hosts including E. coli*(Hermann Bujard, Reiner Gentz, Michael Lanzer, Dietrich Stueber, Michael Mueller, Ibrahim Ibrahimi, Marie-Therese aeuptle, Bernhard Dobberstein, [26] A T5 promoter-based transcription-translation system for the analysis of proteins in Vitro and in Vivo, Methods in Enzymology, Academic Press, Volume 155, 1987, Pages 416-433)* and A. baylyi. Another advantage is that the promoter library that we create would also work in other chassis like E. coli, other industrially important chassis like Cornybacterium glutamicum. However, documentation and characterization of these promoters in other chassis would be required. We have characterized these promoters in A. baylyi ADP1.<br><br>
+
For our project, we used the T5 promoter [BBa_K592008]. T5 is a constitutive promoter that is not under the influence of any protein. It is known to work in a broad range of microorganisms including E. coli, Acinetobacter baylyi ADP1etc. [9]. Another advantage of creating T5 promoter-based library is that they might also work in other chassis like E. coli, other industrially important chassis like Cornybacterium glutamicum. However, documentation and characterization of these promoters in other chassis would be required. We have characterized these promoters in Acinetobacter baylyi ADP1.<br><br>
  
We have classified the promoters we made based on their designing methods into two categories:<br>
+
We have classified the promoters we build based on their designing methods into two categories:<br>
i)P Category: Randomizing the nucleotides flaking -35 and -10 region by conserving their GC content percentage wise in individual regions. We kept the nucleotides immediately next to -35 and -10 regions also same so as to ease the binding of RNA polymerase to the promoter.
+
i)P category: Randomizing the nucleotides flaking -35 and -10 region by conserving their GC content percentage wise in individual regions. Nucleotides flanking -35 and -10 regions were also kept same so as to keep the interaction of RNA polymerase with binding sites unaltered.
 
Care was also taken not to accidentally insert a biobrick restriction or Afl(II) restriction site.
 
Care was also taken not to accidentally insert a biobrick restriction or Afl(II) restriction site.
4 promoters from this category were made
+
<br>
 +
We designed Four promoters from this category were made
 
(BBa_K2857003, BBa_K2857004, BBa_K2857005, BBa_K2857006)<br>
 
(BBa_K2857003, BBa_K2857004, BBa_K2857005, BBa_K2857006)<br>
ii)Q Category:In this approach, we introduced point mutations in BBa_K592008 promoter sequence(in silico). These promoters were selected based on the percentage of similarity they have with T5 BBa_K592008 promoter. Care was taken not to create any restriction site or introduce mutation on -35 and -10 regions. Based on that we selected the promoters having 57% similarity, 66%, 79%, 85% and 91%. We selected two 79% similarity promoters with different sequences. This Method was inspired from Mordaka P. M. et al 2018.
+
ii)Q Category: In this approach, we introduced point mutations in BBa_K592008 promoter sequence (in silico). These promoters were selected based on the percentage of similarity they have with T5 BBa_K592008 promoter. Care was taken not to create any restriction site or introduce mutation on -35 and -10 regions. Based on that we selected the promoters having 57% similarity, 66%, 79%, 85%, and 91%. We selected two 79% similarity promoters with different sequences. This Method was inspired by Mordaka P. M. et al 2018 [10].  
 +
 
 +
<br>
 
<br>
 
<br>
 +
We designed Six  promoters were created using this approach
 +
(Q5:BBa_K2857007, Q6:BBa_K2857008, Q70:BBa_K2857009, Q71:BBa_K2857010, Q9:BBa_K2857011, Q8:BBa_K2857012)
 
<br>
 
<br>
6 promoters were created using this approach: (BBa_K2857007, BBa_K2857008, BBa_K2857009, BBa_K2857010, BBa_K2857011, BBa_K2857012).<br>
 
  
  
Line 146: Line 161:
  
 
<p style="font-size:5.5mm; font-family: 'title', sans-serif;" class="p12 p16" ALIGN=LEFT >
 
<p style="font-size:5.5mm; font-family: 'title', sans-serif;" class="p12 p16" ALIGN=LEFT >
For each of the 10 promtors, we used Salis lab RBS calculator to calculate RBS specific for each promoter, GFP and Acinetobacter baylyi ADP1.</br>
+
For each of the 10 promoters, we used Salis lab RBS calculator to calculate RBS specific for each promoter, GFP and Acinetobacter baylyi ADP1.(https://salislab.net/software/) (Salis, H M. “The Ribosome Binding Site Calculator.” Methods in Enzymology., U.S. National Library of Medicine, www.ncbi.nlm.nih.gov/pubmed/21601672.). These RBS have been named as Biobrick BBa_K2857013-BBa_K2857022.
Next, we assembled the RBS with promoter sequences and got the complete DNA sequence synthesized (BioBrick BBa_K2857111-BBa_K2857120).
+
</br>
The same promoters under iGEM RBS are (BBa_K2857101-BBa_K2857110), which also we got synthesized from the IDT and submitted.
+
Next, we assembled the RBS with promoter sequences and got the complete DNA sequence synthesized (BioBrick BBa_K2857111-BBa_K2857120).<br>
 +
The same promoters under iGEM RBS are (BBa_K2857101-BBa_K2857110), which also we got synthesized from the IDT and submitted.<br>
 +
 
 +
<table>
 +
<tr><th>Promoter</th><th>Promoter BioBrick number</th><th>Corresponding Salis lab RBS BioBrick number</th><th>Complete Assembly(with iGEM RBS)S category</th><th>Complete Assembly (with Salis lab RBS) R category</th>
 +
<th>P1</th><th>BBa_K2857003</th><th>BBa_K2857013</th><th>BBa_K2857001</th><th>BBa_K2857011</th>
 +
<th>P2</th><th>BBa_K2857004</th><th>BBa_K2857014</th><th>BBa_K2857002</th><th>BBa_K2857012</th>
 +
<th>P3</th><th>BBa_K2857005</th><th>BBa_K2857015</th><th>BBa_K2857003</th><th>BBa_K2857013</th>
 +
<th>P4</th><th>BBa_K2857006</th><th>BBa_K2857016</th><th>BBa_K2857004</th><th>BBa_K2857014</th>
 +
<th>Q5</th><th>BBa_K2857007</th><th>BBa_K2857017</th><th>BBa_K2857005</th><th>BBa_K2857015</th>
 +
<th>Q6</th><th>BBa_K2857008</th><th>BBa_K2857018</th><th>BBa_K2857006</th><th>BBa_K2857016</th>
 +
<th>Q70</th><th>BBa_K2857009</th><th>BBa_K2857019</th><th>BBa_K2857007</th><th>BBa_K2857017</th>
 +
<th>Q71</th><th>BBa_K2857010</th><th>BBa_K2857020</th><th>BBa_K2857008</th><th>BBa_K2857018</th>
 +
<th>Q8</th><th>BBa_K2857012</th><th>BBa_K2857022</th><th>BBa_K2857009</th><th>BBa_K2857019</th>
 +
<th>Q9</th><th>BBa_K2857011</th><th>BBa_K2857021</th><th>BBa_K2857010</th><th>BBa_K2857020</th>
 +
 
 +
 
 +
 
 +
 
  
 
</p>
 
</p>
  
  
<span style="padding-right: 25%;"><strong>CUTE, A. baylyi codon usage table and CO-GFP:</strong></span>
+
<span style="padding-right: 25%;"><strong>CUTE, A. baylyi codon usage table and Codon Optimized-GFP:</strong></span>
  
 
<p style="font-size:5.5mm; font-family: 'title', sans-serif;" class="p12 p16" ALIGN=LEFT >
 
<p style="font-size:5.5mm; font-family: 'title', sans-serif;" class="p12 p16" ALIGN=LEFT >
When we contacted GenScript for sending us codon optimized GFP, they did not have reliable data on codon usage table of Acinetobacter baylyi. There was one table available on kasuza which is based only on two CDS.<br>
+
When we contacted GenScript for sending us codon optimized GFP, they did not have reliable data on codon usage table of Acinetobacter baylyi ADP1. There was one table available on kasuza(https://www.kazusa.or.jp/codon/cgi-bin/showcodon.cgi?species=202950) which is based only on two CDS.<br>
We identified this industry based problem that the codon optimizers that they have codon usage table data mainly for standard hosts which are widely used. This is a hindrance in using the unconventional host for one’s studies. So, we created CUTE on the chassidex website. It can be found on <a href="https://cute.chassidex.org">CUTE ChassiDex</a>. This online free tool can be used to generate Codon usage of any organism as long as its CDS annotation is available.<br>
+
We identified this industry based problem that the codon optimizers that they have codon usage table data mainly for standard hosts which are widely used. This is a hindrance in using the unconventional host for one’s studies. So, we created CUTE on the chassidex website. It can be found on <a href="https://cute.chassidex.org">CUTE ChassiDex</a>. This online free tool can be used to generate Codon usage of any organism as long as its CDS annotation is available.<br>
We used CUTE to generate Codon usage table data for A. baylyi ADP1 by taking into consideration the CDS annotation available on the NCBI site. This table can be found on the Results page of our wiki. This table is generated by taking into account at least ***(check)***1174 CDS. We removed putative and hypothetical proteins from the data used to generate the table.<br>
+
We used CUTE to generate Codon usage table data for A. baylyi ADP1 by taking into consideration the CDS annotation available on the NCBI site. This table can be found on the Results page of our wiki. This table is generated by taking into account at least 1194 CDS. We removed putative and hypothetical proteins from the data used to generate the table. <br>
 
Using this codon usage table, we Codon optimized eGFP and mCherry for Acinetobacter baylyi ADP1. We have submitted these Biobrick(BBa_K2857001 GFP and BBa_K2857002 mCherry). <br>
 
Using this codon usage table, we Codon optimized eGFP and mCherry for Acinetobacter baylyi ADP1. We have submitted these Biobrick(BBa_K2857001 GFP and BBa_K2857002 mCherry). <br>
  
 
</p>
 
</p>
  
<span style="padding-right: 35%;"><strong>Further studies of promoters and GFP</strong></span>
+
<span style="padding-right: 35%;"><strong>Assembly of promoters and reporter system in pBAV1k vector</strong></span>
  
 
<p style="font-size:5.5mm; font-family: 'title', sans-serif;" class="p12 p16" ALIGN=LEFT >
 
<p style="font-size:5.5mm; font-family: 'title', sans-serif;" class="p12 p16" ALIGN=LEFT >
iGEM standard vectors pSB1C3 do not replicate in A. baylyi ADP1. So, in the literature, we found pBAV1k which works in A. baylyi. We PCR amplified the backbone such that it amplifies the vector without GFP. So that we can clone GFP in that place.  
+
iGEM standard vectors pSB1C3 does not replicate in A. baylyi ADP1. From the literature, we found that pBAV1k works in A. baylyi[11]. We amplified pBAV1k reporters less version.
For promoter studies, we amplified it such that region from BioBrick prefix to GFP part is amplified but the promoter region is not so that we can clone synthesized promoter there for our studies. <br>
+
For promoter studies, we amplified pBAV1k so as to get promoterless vector backbone where our promoters can be cloned. Similarly, for reporter studies, we amplified pBAV1k such that, we could get reporter-less vector backbone where codon optimized GFP can be placed.
pBAV1k could not be submitted due to the material-transfer agreement but it can be purchased from ADD GENE(https://www.addgene.org/26702/). This is also added as BioBrick (BBa_K1321309). This vector has high copy number and it replicated in a wide range of host (all gram-negative bacteria and some Gram-positive ones).<br>
+
<br>
GFP was cloned in pBAV1k downstream of T5 promoter and RBS. Then fluorometry experiments were carried out.
+
pBAV1k could not be submitted due to the material-transfer agreement but it can be purchased from ADD GENE(https://www.addgene.org/26702/). This is also added as BioBrick (BBa_K1321309). This vector is a high copy, broad host range vector.<br>
Similarly, Promoters were cloned upstream GFP in pBAV1k and then fluorometry studies were carried out.  <br>
+
GFP was cloned in pBAV1k downstream of the T5 promoter and RBS. To measure the strength of Promoter we conducted fluorometry experiments were carried.<br>
 +
Similarly, Promoters were cloned upstream GFP in pBAV1k. To measure the codon-optimized GFP then fluorometry studies were carried out to find out the expression levels.
 +
  <br>
  
 +
<h3 style="font-family: 'title', sans-serif; font-size: 12mm; padding-left: 20%;">References</h3>
  
</p>
+
<center>
  
 +
<div class="box" style="display: block;">
  
 +
<p style="font-size:5.5mm; font-family: 'title', sans-serif;" class="p12 p16" ALIGN=LEFT >
  
 +
<span style="padding-right: 35%;"><strong>References</strong></span>
 +
<ol style="font-size:5.5mm; font-family: 'title', sans-serif;" class="p12 p16" ALIGN=LEFT>
  
 +
<li>Glick, B.R. & Whitney, G.K. Journal of Industrial Microbiology (1987) 1: 277. https://doi.org/10.1007/BF01569305</li>
 +
<li>Blazeck J., Alper H.S. Promoter engineering: recent advances in controlling transcription at the most fundamental level. Biotechnol. J. 2013;8:46–58. doi: 10.1002/biot.201200120.</li>
 +
<li>Synthetic biology toolbox for controlling gene expression in the cyanobacterium Synechococcus sp. strain PCC 7002. Markley AL, Begemann MB, Clarke RE, Gordon GC, Pfleger BF ACS Synth Biol. 2015 May 15; 4(5):595-603.</li>
 +
<li>(Metabolic pathway balancing and its role in the production of biofuels and chemicals. Jones JA, Toparlak ÖD, Koffas MA Curr Opin Biotechnol. 2015 Jun; 33():52-9.)</li>
 +
<li>Use of expression-enhancing terminators in Saccharomyces cerevisiae to increase mRNA half-life and improve gene expression control for metabolic engineering applications. Curran KA, Karim AS, Gupta A, Alper HS Metab Eng. 2013 Sep; 19():88-97. </li>
 +
<li>Codon usage: nature's roadmap to expression and folding of proteins. Angov E Biotechnol J. 2011 Jun; 6(6):650-9.)</li>
 +
<li>Ajikumar P.K., Xiao W.H., Tyo K.E.J., Wang Y., Simeon F., Leonard E., Mucha O., Heng Phon T., Pfeifer B., Stephanopoulos G. Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science. 2010;330:70–74. doi: 10.1126/science.1191652.</li>
 +
<li>Gilman J, Love J. Synthetic promoter design for new microbial chassis. Biochemical Society Transactions. 2016;44(3):731-737. doi:10.1042/BST20160042</li>
 +
<li>(Hermann Bujard, Reiner Gentz, Michael Lanzer, Dietrich Stueber, Michael Mueller, Ibrahim Ibrahimi, Marie-Therese aeuptle, Bernhard Dobberstein, [26] A T5 promoter-based transcription-translation system for the analysis of proteins in vitro and in vivo, Methods in Enzymology, Academic Press, Volume 155, 1987, Pages 416-433)*</li>
 +
<li>Gilman J, Love J. Synthetic promoter design for new microbial chassis. Biochemical Society Transactions. 2016;44(3):731-737. doi:10.1042/BST20160042</li>
 +
<li>(Murin, Charles Daniel, et al. Applied and Environmental Microbiology, American Society for Microbiology, Jan. 2012, )
 +
</li>
 +
<li>Mordaka, Paweł M., and John T. Heap. “Stringency of Synthetic Promoter Sequences in Clostridium Revealed and Circumvented by Tuning Promoter Library Mutation Rates.” ACS Synthetic Biology, vol. 7, no. 2, 2018, pp. 672–681., doi:10.1021/acssynbio.7b00398.</li>
 +
<li>Salis, H M. “The Ribosome Binding Site Calculator.” Methods in Enzymology., U.S. National Library of Medicine, www.ncbi.nlm.nih.gov/pubmed/21601672</li>
 +
</ol>
  
  
  
</div>
 
  
  
</center>
+
</p>
<h3 style="font-family: 'title', sans-serif; font-size: 12mm; padding-left: 20%;">References</h3>
+
  
<center>
 
  
<div class="box" style="display: block;">
 
  
<p style="font-size:5.5mm; font-family: 'title', sans-serif;" class="p12 p16" ALIGN=LEFT >
 
<ol type="1" style="font-size: 5.5mm; " ALIGN=LEFT>
 
  
<li id="1">Lorem ipsum dolor sit amet</li>
 
<li>Lorem ipsum dolor sit amet</li>
 
<li>Lorem ipsum dolor sit amet</li>
 
<li>Lorem ipsum dolor sit amet</li>
 
<li>Lorem ipsum dolor sit amet</li>
 
<li>Lorem ipsum dolor sit amet</li>
 
<li>Lorem ipsum dolor sit amet</li>
 
<li>Lorem ipsum dolor sit amet</li>
 
<li>Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Interdum posuere lorem ipsum dolor. Morbi tristique senectus et netus et. .</li>
 
  
  
  
</ol>
+
</div>
 +
 
 +
 
 +
 
  
</p>
 
 
</div>
 
</div>
  
 
</center>
 
</center>
 
</html>
 
</html>

Revision as of 00:28, 18 October 2018


iGEM Collaborations Page

Team: IIT-Madras/Design

Design

The rationale used in designing parts: (phase dependent promoter and another promoter library)

Introduction:

In synthetic biology and metabolic engineering studies, the level of protein expression is very important. The expression of the protein may be phase depended, inducible or constitutive. There are various factors influencing proteins expression levels.:(Glick et al 1987) :[1]

  • The strength of the promoter[2]
  • The efficiency of RBS[3]
  • Substate cofactor availability[4]
  • The half life of mRNA[5]
  • The metabolic state of the cell
  • Stability of the foreign protein in the cell
  • The abundance of the specific tRNA/Codon Usage table[6]
  • The copy number of the gene encoding the protein of interest[7]
  • Protein interaction with other proteins in a chassis
  • Presence of inducer or signalling molecule for Inducible promoter



In our project, we focused on three factors, ie, Promoters, RBS and codon usage table.

Promoter: it is the region upstream of the gene where RNA polymerase binds and transcription initiates. The binding of RNA polymerase to the promoter is often the rate-limiting step as in a bacterial system where translation and transcription are coupled, unlike eukaryotic system where the mRNA undergoes post-transcriptional modification. Hence promoter sequence is the major translational regulator in gene expression.

RBS: It is the region just upstream of the coding region that binds to the Ribosomal unit and initiates translation. The mRNA conformation at RBS is extremely detrimental in bringing both subunits of ribosome together and initiate translation.

Codon usage: Each species have a different abundance of tRNA. Hence, each species have a different preference for each codon for each amino acids. The abundance of tRNA levels can also make difference in translational rates. By process of Codon optimization, expression of genes can be increased by multiple folds.


Promoters (using random and rational approaches): Promoters usually have a construct as shown below.


In region 1, it has typically about 17 Nucleotides, then the -35 conserved region which is recognized by RNA polymerase while transcription initiation. Then follows Region 2 which is about 17 nucleotides long. -10 follows which is typically TATA box. Another motif that is conserved for promoters. Then follows 6 nucleotides long Region which we named region 3 and then there is a transcription initiation site. This usually starts with A. From this site Transcription starts.

The regions flanking -35 and -10 regions ie Region 1,2 and 3 affect the strength of the promoter [8].

For our project, we used the T5 promoter [BBa_K592008]. T5 is a constitutive promoter that is not under the influence of any protein. It is known to work in a broad range of microorganisms including E. coli, Acinetobacter baylyi ADP1etc. [9]. Another advantage of creating T5 promoter-based library is that they might also work in other chassis like E. coli, other industrially important chassis like Cornybacterium glutamicum. However, documentation and characterization of these promoters in other chassis would be required. We have characterized these promoters in Acinetobacter baylyi ADP1.

We have classified the promoters we build based on their designing methods into two categories:
i)P category: Randomizing the nucleotides flaking -35 and -10 region by conserving their GC content percentage wise in individual regions. Nucleotides flanking -35 and -10 regions were also kept same so as to keep the interaction of RNA polymerase with binding sites unaltered. Care was also taken not to accidentally insert a biobrick restriction or Afl(II) restriction site.
We designed Four promoters from this category were made (BBa_K2857003, BBa_K2857004, BBa_K2857005, BBa_K2857006)
ii)Q Category: In this approach, we introduced point mutations in BBa_K592008 promoter sequence (in silico). These promoters were selected based on the percentage of similarity they have with T5 BBa_K592008 promoter. Care was taken not to create any restriction site or introduce mutation on -35 and -10 regions. Based on that we selected the promoters having 57% similarity, 66%, 79%, 85%, and 91%. We selected two 79% similarity promoters with different sequences. This Method was inspired by Mordaka P. M. et al 2018 [10].

We designed Six promoters were created using this approach (Q5:BBa_K2857007, Q6:BBa_K2857008, Q70:BBa_K2857009, Q71:BBa_K2857010, Q9:BBa_K2857011, Q8:BBa_K2857012)
Since, this library is created out of T5 promoter, which is known to work in multiple chassis, the library that we created should also work in various chassis like almost all E. coli strains, A. baylyi, L. lactis.

Ribosome Binding Site

For each of the 10 promoters, we used Salis lab RBS calculator to calculate RBS specific for each promoter, GFP and Acinetobacter baylyi ADP1.(https://salislab.net/software/) (Salis, H M. “The Ribosome Binding Site Calculator.” Methods in Enzymology., U.S. National Library of Medicine, www.ncbi.nlm.nih.gov/pubmed/21601672.). These RBS have been named as Biobrick BBa_K2857013-BBa_K2857022.
Next, we assembled the RBS with promoter sequences and got the complete DNA sequence synthesized (BioBrick BBa_K2857111-BBa_K2857120).
The same promoters under iGEM RBS are (BBa_K2857101-BBa_K2857110), which also we got synthesized from the IDT and submitted.

CUTE, A. baylyi codon usage table and Codon Optimized-GFP:

When we contacted GenScript for sending us codon optimized GFP, they did not have reliable data on codon usage table of Acinetobacter baylyi ADP1. There was one table available on kasuza(https://www.kazusa.or.jp/codon/cgi-bin/showcodon.cgi?species=202950) which is based only on two CDS.
We identified this industry based problem that the codon optimizers that they have codon usage table data mainly for standard hosts which are widely used. This is a hindrance in using the unconventional host for one’s studies. So, we created CUTE on the chassidex website. It can be found on CUTE ChassiDex. This online free tool can be used to generate Codon usage of any organism as long as its CDS annotation is available.
We used CUTE to generate Codon usage table data for A. baylyi ADP1 by taking into consideration the CDS annotation available on the NCBI site. This table can be found on the Results page of our wiki. This table is generated by taking into account at least 1194 CDS. We removed putative and hypothetical proteins from the data used to generate the table.
Using this codon usage table, we Codon optimized eGFP and mCherry for Acinetobacter baylyi ADP1. We have submitted these Biobrick(BBa_K2857001 GFP and BBa_K2857002 mCherry).

Assembly of promoters and reporter system in pBAV1k vector

iGEM standard vectors pSB1C3 does not replicate in A. baylyi ADP1. From the literature, we found that pBAV1k works in A. baylyi[11]. We amplified pBAV1k reporters less version. For promoter studies, we amplified pBAV1k so as to get promoterless vector backbone where our promoters can be cloned. Similarly, for reporter studies, we amplified pBAV1k such that, we could get reporter-less vector backbone where codon optimized GFP can be placed.
pBAV1k could not be submitted due to the material-transfer agreement but it can be purchased from ADD GENE(https://www.addgene.org/26702/). This is also added as BioBrick (BBa_K1321309). This vector is a high copy, broad host range vector.
GFP was cloned in pBAV1k downstream of the T5 promoter and RBS. To measure the strength of Promoter we conducted fluorometry experiments were carried.
Similarly, Promoters were cloned upstream GFP in pBAV1k. To measure the codon-optimized GFP then fluorometry studies were carried out to find out the expression levels.

References

References

  1. Glick, B.R. & Whitney, G.K. Journal of Industrial Microbiology (1987) 1: 277. https://doi.org/10.1007/BF01569305
  2. Blazeck J., Alper H.S. Promoter engineering: recent advances in controlling transcription at the most fundamental level. Biotechnol. J. 2013;8:46–58. doi: 10.1002/biot.201200120.
  3. Synthetic biology toolbox for controlling gene expression in the cyanobacterium Synechococcus sp. strain PCC 7002. Markley AL, Begemann MB, Clarke RE, Gordon GC, Pfleger BF ACS Synth Biol. 2015 May 15; 4(5):595-603.
  4. (Metabolic pathway balancing and its role in the production of biofuels and chemicals. Jones JA, Toparlak ÖD, Koffas MA Curr Opin Biotechnol. 2015 Jun; 33():52-9.)
  5. Use of expression-enhancing terminators in Saccharomyces cerevisiae to increase mRNA half-life and improve gene expression control for metabolic engineering applications. Curran KA, Karim AS, Gupta A, Alper HS Metab Eng. 2013 Sep; 19():88-97.
  6. Codon usage: nature's roadmap to expression and folding of proteins. Angov E Biotechnol J. 2011 Jun; 6(6):650-9.)
  7. Ajikumar P.K., Xiao W.H., Tyo K.E.J., Wang Y., Simeon F., Leonard E., Mucha O., Heng Phon T., Pfeifer B., Stephanopoulos G. Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science. 2010;330:70–74. doi: 10.1126/science.1191652.
  8. Gilman J, Love J. Synthetic promoter design for new microbial chassis. Biochemical Society Transactions. 2016;44(3):731-737. doi:10.1042/BST20160042
  9. (Hermann Bujard, Reiner Gentz, Michael Lanzer, Dietrich Stueber, Michael Mueller, Ibrahim Ibrahimi, Marie-Therese aeuptle, Bernhard Dobberstein, [26] A T5 promoter-based transcription-translation system for the analysis of proteins in vitro and in vivo, Methods in Enzymology, Academic Press, Volume 155, 1987, Pages 416-433)*
  10. Gilman J, Love J. Synthetic promoter design for new microbial chassis. Biochemical Society Transactions. 2016;44(3):731-737. doi:10.1042/BST20160042
  11. (Murin, Charles Daniel, et al. Applied and Environmental Microbiology, American Society for Microbiology, Jan. 2012, )
  12. Mordaka, Paweł M., and John T. Heap. “Stringency of Synthetic Promoter Sequences in Clostridium Revealed and Circumvented by Tuning Promoter Library Mutation Rates.” ACS Synthetic Biology, vol. 7, no. 2, 2018, pp. 672–681., doi:10.1021/acssynbio.7b00398.
  13. Salis, H M. “The Ribosome Binding Site Calculator.” Methods in Enzymology., U.S. National Library of Medicine, www.ncbi.nlm.nih.gov/pubmed/21601672

PromoterPromoter BioBrick numberCorresponding Salis lab RBS BioBrick numberComplete Assembly(with iGEM RBS)S categoryComplete Assembly (with Salis lab RBS) R category P1BBa_K2857003BBa_K2857013BBa_K2857001BBa_K2857011 P2BBa_K2857004BBa_K2857014BBa_K2857002BBa_K2857012 P3BBa_K2857005BBa_K2857015BBa_K2857003BBa_K2857013 P4BBa_K2857006BBa_K2857016BBa_K2857004BBa_K2857014 Q5BBa_K2857007BBa_K2857017BBa_K2857005BBa_K2857015 Q6BBa_K2857008BBa_K2857018BBa_K2857006BBa_K2857016 Q70BBa_K2857009BBa_K2857019BBa_K2857007BBa_K2857017 Q71BBa_K2857010BBa_K2857020BBa_K2857008BBa_K2857018 Q8BBa_K2857012BBa_K2857022BBa_K2857009BBa_K2857019 Q9BBa_K2857011BBa_K2857021BBa_K2857010BBa_K2857020